Jane A. Gross - 26 Apr 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
/s/ Nancy E. Denyes, attorney-in-fact
Issuer symbol
LIFE
Transactions as of
26 Apr 2023
Transactions value $
$0
Form type
4
Filing time
28 Apr 2023, 16:52:18 UTC
Previous filing
01 Aug 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common stock Options Exercise +6,000 6,000 26 Apr 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Restricted Stock Unit Options Exercise $0 -6,000 -100% $0.000000* 0 26 Apr 2023 Common Stock 6,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
F2 RSUs convert into common stock on a one-for-one basis.
F3 The RSUs fully vested one year from the grant date which was April 26, 2022.